Urinary excretion of 3-hydroxyisovaleric acid and 3-hydroxyisovaleryl carnitine increases in response to a leucine challenge in marginally biotin-deficient humans 1,2

Journal of Nutrition

Volumn 141, Issue 11, 2011, Pages 1925-1930

  Mock, Donald M ^a   Stratton, Shawna L ^a   Horvath, Thomas D ^a   Bogusiewicz, Anna ^a   Matthews, Nell I ^a   Henrich, Cindy L ^b   Dawson, Amanda M ^b   Spencer, Horace J ^a,b   Owen, Suzanne N ^d   Boysen, Gunnar ^c   Moran, Jeffery H ^a,d  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^d ARKANSAS DEPARTMENT OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYISOVALERIC ACID; 3 HYDROXYISOVALERYL CARNITINE; ACYL COENZYME A; EGG WHITE; LEUCINE; METHYLCROTONOYL COENZYME A CARBOXYLASE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BIOTIN DEFICIENCY; CATABOLISM; CLINICAL INDICATOR; DISEASE COURSE; ENZYME ACTIVITY; ENZYME MECHANISM; FEMALE; FOOD INTAKE; HUMAN; NORMAL HUMAN; PROVOCATION TEST; SENSITIVITY ANALYSIS; URINALYSIS; URINARY EXCRETION; VITAMIN DEFICIENCY; VITAMIN SUPPLEMENTATION;

ADULT; BIOTIN; CARNITINE; COHORT STUDIES; FEMALE; HUMANS; LEUCINE; MALE; VALERATES;

EID: 81055126892     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.111.146126     Document Type: Article

References (43)

1. Mock DM, Stadler DD. Conflicting indicators of biotin status from a cross-sectional study of normal pregnancy. J Am Coll Nutr. 1997; 16:252-7.
2. Mock DM, Stadler DD, Stratton SL, Mock NI. Biotin status assessed longitudinally in pregnant women. J Nutr. 1997;127:710-6.
3. Watanabe T, Endo A. Teratogenic effects of avidin-induced biotin deficiency in mice. Teratology. 1984;30:91-4.
4. Watanabe T, Endo A. Species and strain differences in teratogenic effects of biotin deficiency in rodents. J Nutr. 1989;119:255-61.
5. Watanabe T. Teratogenic effects of biotin deficiency in mice. J Nutr. 1983;113:574-81.
6. Watanabe T, Endo A. Teratogenic effects of maternal biotin deficiency in mouse embryos examined at midgestation. Teratology. 1990;42: 295-300.
7. Watanabe T. Dietary biotin deficiency affects reproductive function and prenatal development in hamsters. J Nutr. 1993;123:2101-8.
8. Watanabe T, Dakshinamurti K, Persaud TVN. Biotin influences palatal development of mouse embryos in organ culture. J Nutr. 1995;125: 2114-21.
9. Watanabe T, Endo A. Biotin deficiency per se is teratogenic in mice. J Nutr. 1991;121:101-4.
10. Takechi R, Taniguchi A, Ebara S, Fukui T, Watanabe T. Biotin deficiency affects the proliferation of human embryonic palatal mesenchymal cells in culture. J Nutr. 2008;138:680-4.
11. Mock DM, Mock NI, Stewart CW, LaBorde JB, Hansen DK. Marginal biotin deficiency is teratogenic in ICR mice. J Nutr. 2003;133:2519-25.
12. Sealey WM, Stratton SL, Hansen DK, Mock DM. Marginal maternal biotin deficiency in CD-1 mice reduces fetal mass of biotin-dependent carboxylases. J Nutr. 2005;135:973-7.
13. Mock DM. Biotin. In: Ziegler EE, Filer LJ Jr, editors. Present knowledge in nutrition. 7th ed. p. 220-35. Washington, DC: International Life Sciences Institutes-Nutrition Foundation; 1996.
14. Mock DM. Marginal biotin deficiency is common in normal human pregnancy and is highly teratogenic in the mouse. J Nutr. 2009;139: 154-7.
15. Said HM. Biotin bioavailability and estimated average requirement: why bother? Am J Clin Nutr. 1999;69:352-3.
16. Okayama A, Fun L, Yamatodani A, Ogawa Y, Wada H, Goto S. Effect of exposure to carbon disulfide on tryptophan metabolism and the tissue vitamin B6 contents of rats. Arch Toxicol. 1987;60:450-3.
17. Coon WW, Nagler E. The tryptophan load as a test for pyridoxine deficiency in hospitalized patients. Ann N Y Acad Sci. 1969;166:30-43.
18. Coon WW. Tryptophan load and pyridoxine deficiency. Am J Clin Pathol. 1966;46:345.
19. Mohamed SD, Roberts M. Relative importance of formiminoglutamic and urocanic acid excretion after a histidine load. J Clin Pathol. 1966;19:37-42.
20. Ubbink JB, Van Der Merwe A, Delport R, Allen R, Stabler S, Riezler R, Vermaak W. The effect of a subnormal vitamin B-6 status on homocysteine metabolism. J Clin Invest. 1996;98:177-84.
21. Selhub J. Homocysteine metabolism. Annu Rev Nutr. 1999;19:217-46.
22. Sweetman L, Williams JC. Branched chain organic acidurias. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited disease. 7th ed. New York: McGraw-Hill Inc; 1995. p. 1387-1422.
23. Maeda Y, Ito T, Ohmi H, Yokoi K, Nakajima Y, Ueta A, Kurono Y, Togari H, Sugiyama N. Determination of 3-hydroxyisovalerylcarnitine and other acylcarnitine levels using liquid chromatography-tandem mass spectrometry in serum and urine of a patient with multiple carboxylase deficiency. J Chromatogr B Analyt Technol Biomed Life Sci. 2008;870:154-9.
24. Rö schinger W, Millington DS, Gage DA, Huang ZH, Iwamoto T, Yano S, Packman S, Johnston K, Berry SA, Sweetman L. 3-Hydroxyisovalerylcarnitine in patients with deficiency of 3-methylcrotonyl CoA carboxylase. Clin Chim Acta. 1995;240:35-51.
25. Pasquali M, Monsen G, Richardson L, Alston M, Longo N. Biochemical findings in common inborn errors of metabolism. Am J Med Genet C Semin Med Genet. 2006;142C:64-76.
26. Stratton SL, Horvath TD, Bogusiewicz A, Matthews NI, Henrich CL, Spencer HJ, Moran JH, Mock DM. Plasma concentration of 3-hydroxyisovaleryl carnitine is an early and sensitive indicator of marginal biotin deficiency in humans. Am J Clin Nutr. 2010;92:1399-405.
27. Mock NI, Malik MI, Stumbo PJ, Bishop WP, Mock DM. Increased urinary excretion of 3-hydroxyisovaleric acid and decreased urinary excretion of biotin are sensitive early indicators of decreased status in experimental biotin deficiency. Am J Clin Nutr. 1997;65:951-8.
28. Mock DM, Jackson H, Lankford GL, Mock NI, Weintraub ST. Quantitation of urinary 3-hydroxyisovaleric acid using deuterated 3-hydroxyisovaleric acid as internal standard. Biomed Environ Mass Spectrom. 1989;18:652-6.
29. Stratton SL, Horvath TD, Bogusiewicz A, Matthews NI, Henrich CL, Spencer HJ, Moran JH, Mock DM. Urinary excretion of 3-hydroxyisovaleryl carnitine is an early and sensitive indicator of marginal biotin deficiency in humans. J Nutr. 2011;141:353-8.
30. Mock DM, Henrich CL, Carnell N, Mock NI. Indicators of marginal biotin deficiency and repletion in humans: validation of 3-hydroxyisovaleric acid excretion and a leucine challenge. Am J Clin Nutr. 2002;76:1061-8.
31. NRC. Dietary reference intakes tables-the complete set (pdf). In: Food and Nutrition Board Institute of Medicine, editor. Dietary reference intakes. Washington, DC: The National Academies; 2005.
32. Mock D, Henrich CL, Carnell N, Mock NI, Swift L. Lymphocyte propionyl-CoA carboxylase and accumulation of odd-chain fatty acid in plasma and erythrocytes are useful indicators of marginal biotin deficiency. J Nutr Biochem. 2002;13:462-70.
33. Vlasova TI, Stratton SL, Wells AM, Mock NI, Mock DM. Biotin deficiency reduces expression of SLC19A3, a potential biotin transporter, in leukocytes from human blood. J Nutr. 2005;135:42-7.
34. Mock DM. Rayon balls and disposable-diaper material selectively adsorb creatinine. Am J Clin Nutr. 1992;55:326-30.
35. Horvath TD, Matthews NI, Stratton SL, Mock DM, Boysen G. Measurement of 3-hydroxyisovaleric acid in urine from marginally biotin deficient humans by UPLC-MS/MS. Anal Bioanal Chem. In press. 2011.
36. Horvath TD, Stratton SL, Bogusiewicz A, Owen SO, Mock DM, Moran JH. Quantitative measurement of urinary excretion of 3-hydroxyisovaleryl carnitine by LC-MS/MS as an indicator of biotin status in humans. Anal Chem. 2010;82:9543-8.
37. Horvath TD, Stratton SL, Bogusiewicz A, Pack L, Moran J, Mock DM. Quantitative measurement of plasma 3-hydroxyisovaleryl carnitine by LC-MS/MS as a novel biomarker of biotin status in humans. Anal Chem. 2010;82:4140-4.
38. Stratton SL, Bogusiewicz A, Mock MM, Mock NI, Wells AM, Mock DM. Lymphocyte propionyl-CoA carboxylase and its activation by biotin are sensitive indicators of marginal biotin deficiency in humans. Am J Clin Nutr. 2006;84:384-8.
39. Zammit VA, Ramsay RR, Bonomini M, Arduini A. Carnitine, mitochondrial function and therapy. Adv Drug Deliv Rev. 2009;61:1353-62.
40. Westin MA, Hunt MC, Alexson SE. Short- and medium-chain carnitine acyltransferases and acyl-CoA thioesterase in mouse provide complementary systems for transport of beta-oxidation products out of peroxisomes. Cell Mol Life Sci. 2008;65:982-90.
41. Ramsay RR. The carnitine acyltransferases: modulators of acyl-CoAdependent reactions. Biochem Soc Trans. 2000;28:182-6.
42. Baumgartner M. Molecular mechanism of dominant expression in 3-methylcrotonyl-CoA carboxylase deficiency. J Inherit Metab Dis. 2005;28:301-9.
43. Baumgartner MR, Dantas MF, Suormala T, Almashanu S, Giunta C, Friebel D, Gebhardt B, Fowler B, Hoffmann GF, Baumgartner ER, Valle D. Isolated 3-methylcrotonyl-CoA carboxylase deficiency: evidence for an allele-specific dominant negative effect and responsiveness to biotin therapy. Am J Hum Genet. 2004;75:790-800.